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Abstract Gene expression in blood was correlated with
mercury levels in blood of 2- to 5-year-old boys with
autism (AU) compared to age-matched typically develop-
ing (TD) control boys. This was done to address the pos-
sibility that the two groups might metabolize toxicants,
such as mercury, differently. RNA was isolated from blood
and gene expression assessed on whole genome Affymetrix
Human U133 expression microarrays. Mercury levels were
measured using an inductively coupled plasma mass
spectrometer. Analysis of covariance (ANCOVA) was
performed and partial correlations between gene expres-
sion and mercury levels were calculated, after correcting
for age and batch effects. To reduce false positives, only
genes shared by the ANCOVA models were analyzed. Of
the 26 genes that correlated with mercury levels in both AU
and TD boys, 11 were signiﬁcantly different between the
groups (P(Diagnosis*Mercury) B 0.05). The expression of
a large number of genes (n = 316) correlated with mercury
levels in TD but not in AU boys (P B 0.05), the most
represented biological functions being cell death and cell
morphology. Expression of 189 genes correlated with
mercury levels in AU but not in TD boys (P B 0.05),
the most represented biological functions being cell
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DOI 10.1007/s12640-009-9137-7morphology, amino acid metabolism, and antigen presen-
tation. These data and those in our companion study on
correlation of gene expression and lead levels show that
AU and TD children display different correlations between
transcript levels and low levels of mercury and lead. These
ﬁndings might suggest different genetic transcriptional
programs associated with mercury in AU compared to TD
children.
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Abbreviations
ABL1 c-abloncogene1,receptortyrosinekinase
ALDH3B1 Aldehyde dehydrogenase 3 family,
member B1
ALS2 Amyotrophic lateral sclerosis 2
(juvenile)
AP2A2 Adaptor-related protein complex 2,
alpha 2 subunit
BAD BCL2-antagonist of cell death
BCL2L11 BCL2-like 11 (apoptosis facilitator)
BDNF Brain-derived neurotrophic factor
BMPR2 Serine/threonine receptor kinase
BRAF V-raf murine sarcoma viral oncogene
homolog B1
CADM1 Cell adhesion molecule 1
CDKN2AIPNL CDKN2A interacting protein N terminal
like
CHCHD4 Coiled-coil-helix-coiled-coil-helix
domain containing 4
CXorf34 Chromosome X open reading frame 34
ELOVL1 Elongation of very long chain fatty
acids (FEN1/Elo2, SUR4/Elo3, yeast)
-like 1
FEZ2 Fasciculation and elongation protein
zeta 2 (zygin II)
FLNB Filamin B, beta (actin binding protein
278)
GCLM Glutamate-cysteine ligase, modiﬁer
subunit
GGT Gamma-glutamyltransferase
GNLY Granulysin
GPCRs G Protein-coupled receptors
HLA-DQA1 Major histocompatibility complex, class
II, DQ alpha 1
HLA-DQB1 major histocompatibility complex, class
II, DQ beta 1
KRT1 Keratin 1 (epidermolytic
hyperkeratosis)
LMLN Leishmanolysin-like (metallopeptidase
M8 family)
LOC100129026 Hypothetical protein LOC100129026
MAPK Mitogen-activated protein kinases;
serine/threonine receptor kinases
MSH6 mutS homolog 6 (E. coli)
MUC1 Mucin 1, cell surface associated
MYBBP1A MYB binding protein (P160) 1a
NCAPD3 Non-SMC condensin II complex,
subunit D3
NFATC4 Nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 4
NTHL1 nth endonuclease III-like 1 (E. coli)
NTRK3 Neurotrophic tyrosine kinase, receptor,
type 3
PMCH Pro-melanin-concentrating hormone
PXDN Peroxidasin homolog (Drosophila)
RPS9 Ribosomal protein S9
RTN4 Reticulon 4
SCARB1 Scavenger receptor class B, member 1
SFRP1 Secreted frizzled-related protein 1
SLC25A22 Solute carrier family 25 (mitochondrial
carrier: glutamate), member 22
SLC7A8 Solute carrier family 7 (cationic amino
acid transporter, y? system), member 8
SMAD2 SMAD family member 2
SSTR3 Somatostatin receptor 3
SUB1 SUB1 homolog (S. cerevisiae)
TCF3 T-cell factor; transcription factor
TXNDC17 Thioredoxin domain containing 17
VPS25 Vacuolar protein sorting 25 homolog
(S. cerevisiae)
ZBTB16 ZincﬁngerandBTBdomaincontaining16
ZMYM6 Zinc ﬁnger, MYM-type 6
Introduction
Autism (AU) is a neurodevelopmental disorder character-
ized by impaired social interactions and impaired verbal
and nonverbal communication as well as restricted, ste-
reotyped patterns of behavior and interests. The etiol-
ogy(ies) of autism remains elusive. The interactions of
multiple genetic, environmental, and epigenetic factors are
postulated to be involved (Ashwood et al. 2006; Hertz-
Picciotto et al. 2006; London 2000). Exposures to heavy
metals have received much attention because of their
developmental neurotoxicity (WHO 1990, 1991; Tchoun-
wou et al. 2003; Clarkson and Magos 2006). Mercury is a
toxic and hazardous heavy metal that is ubiquitous in the
environment, being found in ﬁsh, thermometers, dental
amalgams, and in the atmosphere and affects multiple
organ systems (WHO 1990, 1991; Tchounwou et al. 2003;
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Zahir et al. 2005). In animals, mercury binds to the
endogenous tripeptide glutathione (GSH), and the resulting
mercury–glutathione complex is metabolized by the ecto-
proteins gamma-glutamyl transpeptidase (GGT) and
dipeptidase (Rice 2008; Newland et al. 2008; Guzzi and La
Porta 2008). Mercury is then eliminated as GSH conju-
gates, GSH being produced by glutamyl-cysteine ligase
(GCL) and conjugation by glutathione S-transferases
(GST). The high afﬁnity of mercury for sulfhydryl, and to a
lesser degree hydroxyl, carboxyl, and phosphoryl groups of
structural and functional proteins, is believed to be the
biochemical basis for its harmful effects on biological
systems (Clarkson and Magos 2006).
The element mercury exists in three species: elemental
mercury (Hg
o), inorganic mercury compounds (primarily
mercuric chloride), and organic mercury (primarily meth-
ylmercury). Exposure to each mercury species can cause
general as well as speciﬁc toxic effects in children and
adults (Clarkson and Magos 2006; Counter and Buchanan
2004). For example, methylmercury derived mostly from
ﬁsh consumption passes through the blood–brain barrier as
an L-cysteine complex via the L-amino acid transporter
(Clarkson and Magos 2006; Mokrzan et al. 1995). The
mechanisms by which inorganic mercury damages human
brain, however, are poorly understood. The different mer-
cury species have different absorption, distribution,
metabolism, excretion, and toxicity (Guzzi and La Porta
2008; Ercal et al. 2001; Quig 1998). In addition, the effect
of a toxicant can be inﬂuenced by another substance, so-
called ‘‘mixture toxicity’’ (Rice 2008; Newland et al. 2008;
McCarty and Borgert 2006a, b).
The development of whole genome microarrays has
made it possible to characterize how the entire transcrip-
tome of cells or organisms responds to changes in external
or internal environments. Measurements of gene expres-
sion (RNA) levels provide a ‘‘transcriptional signature’’ of
an individual’s genetic, physiological, and environmental
status. The relationship between levels of xenobiotics and
transcriptional signatures measured in blood can be used to
provide mechanistic information about toxic exposures
(Yoon et al. 2008).
The objective of the current study was to analyze the
entire transcriptome in similar aged typically developing
(TD) and AU boys to identify those genes whose expres-
sion level in blood correlated with relatively low total
mercury (Hg) levels in blood. Moreover, the correlations of
RNA levels with Hg levels might differ in AU compared to
TD boys. Lastly, we postulated that differences in RNA
expression signatures for AU compared to TD boys would
occur not only for Hg but would also be different for other
xenobiotics including lead (Tian et al. 2009, accompanying
paper). This study begins to address these hypotheses.
Materials and Methods
Subjects
Subjects were participants in the CHARGE study (Hertz-
Picciotto et al. 2006). These children were assessed at the
UC Davis Medical Investigations of Neurodevelopmental
Disorders (M.I.N.D.) Institute. Each child was evaluated
using standardized clinical assessments. AU cases were
assessed using the Autism Diagnostic Interview–Revised
(ADI-R) (Le Couteur et al. 2003;L o r de ta l .1994, 1997)
and the Autism Diagnostic Observation Schedules
(ADOS) (Lord et al. 2000, 2003). For this study of gene
expression versus Hg levels, we analyzed boys with AU
(n = 33, mean age 45.3 with a range of 31–60 months)
and age-matched TD control boys (n = 51, mean age
43.3 with a range of 28–57 months). Only subjects for
whom the Affymetrix expression data was generated in
2007–2008 were analyzed because Affymetrix arrays
processed prior to those times were done using a different
protocol which resulted in signiﬁcant technical variation.
Only boys were analyzed in our study because there were
few girls who had both Affymetrix expression data and
blood Hg data. The subjects used in our companion study
on correlation between gene expression and blood lead
levels are different from the ones used in this study.
Parents provided informed consent for all subjects (Tian
et al. 2009). The study was approved by the Institutional
Review Board at University of California Davis Medical
Center and was conducted in accordance with the Dec-
laration of Helsinki.
Hg Analysis
Total blood Hg was measured on an Agilent 7500i
Inductively Coupled Plasma Mass Spectrometer (ICP-MS)
(Agilent, Palo Alto, CA) in the UCD Department of Civil
and Environmental Engineering. Detailed methods are
included in our previous publication (Hertz-Picciotto et al.
2009). Blood Hg concentrations were log2-transformed due
to the skewed distribution over a wide range of values
(Fig. 2). The normality of the distributions was assessed by
performing the Kolmogorov–Smirnov test in Partek
Genomics Suite 6.4. The detection limit for Hg was
0.02 lg/l (Hertz-Picciotto et al. 2009), with the (slightly)
lower detection limit of 0.01 lg/l (limit of barely detected).
Log2-transformation of the Hg levels was performed to
produce a more linear distribution of the values and to
match the log2-transformation of gene expression (see
below). For log2-transformation of the Hg data, Hg levels
below detection levels were assigned a value of 0.009 lg/l.
The value of 0.009 was selected to be slightly lower than
the lower limit of Hg detection of 0.01 lg/l in order to not
Neurotox Res (2011) 19:31–48 33
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the correlation coefﬁcient.
RNA Isolation and Affymetrix Array Hybridizations
Whole blood was collected and total RNA was isolated
using PAXgene tubes and kits (Qiagen, Valencia, CA).
RNA concentration and purity were checked using a
Nanodrop ND-1000 spectrophotometer, and integrity was
checked using the Agilent 2100 Bioanalyzer (260/280[2.0;
28S/18S[1.5; RIN[8).
Human whole genome U133 Plus 2.0 GeneChip
microarrays (Affymetrix; Santa Clara, CA), surveying over
54,000 probe sets, were used. The 54,000 probe sets rep-
resent over 38,500 potential human genes (Affymetrix
Manual). The standard Affymetrix protocol was followed
for the sample labeling, hybridization, and image scanning.
Statistical Analysis
Analysis of Affymetrix Expression Array Data
Raw gene expression values from Affymetrix.cel ﬁles were
imported into Partek Genomics Suit, version 6.4, release
6.09.0422 (Partek Inc., St. Louis, MI). Probe summariza-
tion and probe set normalization were performed using the
GC-RMA algorithm (Wu and Irizarry 2004), including
GC-RMA background correction, Quantile Normalization,
log2-transformation, and Median Polish probe set
summarization.
Analysis of Covariance
Analysis of covariances (ANCOVAs) were performed in
Partek Genomics Suite, version 6.4, release 6.09.0422
(Partek Inc., St. Louis, MI). We estimated the partial cor-
relations between log2-transformed gene expression and
log2-transformed Hg levels while removing the effects of
age and microarray technical variation (batch) (Eisenhart
1947). Partial correlation coefﬁcients describe the linear
relation between two variables (in our case, gene expres-
sion and Hg level) while controlling for the effects of one
or more additional variables (Morrison 1976). Correlations
are a measure of linear association. A positive partial
correlation between Hg level and gene expression indicates
that gene expression is increasing when Hg levels are
increasing. Similarly, a negative partial correlation indi-
cates that gene expression is decreasing when Hg levels are
increasing. We performed the ANCOVA on several models
(see below). We overlapped these gene lists (Fig. 1)t o
reduce the large false discovery rates due to multiple
comparisons between thousands of genes. The following
ANCOVA models were used.
Model 1: TD Boys Only Log2(Gene Expression) is a
function of the following factors: Log2Hg (continuous),
Age (continuous), and Batch (categorical). Genes with a
P(Log2(Hg)) B 0.05 in this model would be associated
with the left circle in Fig. 1.
Model 2: AU Boys Only Log2(Gene Expression) is a
function of the following factors: Log2Hg (continuous),
Age (continuous), and Batch (categorical). Genes with a
P(Log2(Hg)) B 0.05 in this model would be associated
with the right circle in Fig. 1.
Model 3: AU and TD Boys Combined Log2(Gene Expres-
sion) is a function of the following factors: Log2Hg (con-
tinuous), Age (continuous), Batch (categorical), Diagnosis
(binary categorical), and interaction Diagnosis*Log2Hg.
Fig. 1 Analysis design—Venn diagram of the three ANCOVA
models used to generate the genes signiﬁcantly correlating with
mercury (Hg) levels. GE gene expression, TD typically developing
control children from the general population, AU children with
autism, Batch a group of microarrays that were processed together.
Gene List A genes whose expression correlates with Log2Hg levels in
each of the TD and AU models separately (P(Log2Hg) B 0.05), with
no signiﬁcant differences in the correlations between the two groups
in the combined AU ? TD model (P(Diagnosis*Log2Hg)[0.05).
Gene List B genes whose expression correlates with Log2Hg levels in
each of the TD and AU models separately (P(Log2Hg) B 0.05), and
had signiﬁcant differences in the correlations between the two groups
in the combined AU ? TD model (P(Diagnosis*Log2Hg) B 0.05).
Gene List C genes whose expression correlates with Log2Hg levels in
the TD model (P(Log2Hg) B 0.05) but not in the AU model
(P(Log2Hg)[0.05), and which had signiﬁcant differences in the
correlations between the two groups in the combined AU ? TD
model (P(Diagnosis*Log2Hg) B 0.05). Gene List D represents genes
whose expression correlates with Log2Hg levels in the AU model
(P(Log2Hg) B 0.05) but not in the TD model (P(Log2Hg)[0.05),
and which had signiﬁcant differences in the correlations between the
two groups in the combined AU ? TD model (P(Diagnosis*Log2Hg)
B 0.05)
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associated with the top circle in Fig. 1.
Batch in all three models is a random effect. We focused
on gene lists that came from the combined analyses to
minimize the false discovery rate (Fig. 1, intersections
labeled A–D).
• GenelistArepresentsgeneswhoseexpressioncorrelates
with Log2Hg levels in each of the TD and AU models
separately (P(Log2Hg) B 0.05), with no signiﬁcant dif-
ferencesinthecorrelationsbetweenthetwogroupsinthe
combined AU ? TD model (P(Diagnosis*Log2Hg)
[0.05).
• Gene list B represents genes whose expression corre-
lates with Log2Hg levels in each of the TD and AU
models separately (P(Log2Hg) B 0.05), and had sig-
niﬁcant differences in the correlations between the two
groups in the combined AU ? TD model (P(Diagno-
sis*Log2Hg) B 0.05).
• Gene list C represents genes whose expression correlates
withLog2HglevelsintheTDmodel(P(Log2Hg) B 0.05)
but not in the AU model (P(Log2Hg)[0.05), and which
had signiﬁcantdifferences inthe correlationsbetweenthe
two groups in the combined AU ? TD model
(P(Diagnosis*Log2Hg) B 0.05).
• Gene list D represents genes whose expression corre-
lates with Log2Hg levels in the AU model (P(Log2Hg)
B 0.05) but not in the TD model (P(Log2Hg)[0.05),
and which had signiﬁcant differences in the correlations
between the two groups in the combined AU ? TD
model (P(Diagnosis*Log2Hg) B 0.05).
Assessment of Possible Biological Signiﬁcance of Identiﬁed
Genes
GeneontologyannotationwasobtainedfromtheAffymetrix
NetAfﬁxdatabase(www.affymetrix.com).Pathwayanalysis
was performed using Ingenuity Pathways Analysis (IPA)
(Ingenuity Systems
 , www.ingenuity.com). A dataset con-
taininggeneidentiﬁers(calledfocusmolecules)fromeachof
thelists (A,B,C,orD)wasuploadedintotheprogram.Each
identiﬁer was mapped to its corresponding gene object and
overlaid onto a global molecular network developed from
informationcontainedinthe Ingenuity knowledgebase. The
Bio Functional Analysis identiﬁed the biological functions
and/or diseases that were most signiﬁcant to the dataset.
Canonical Pathway Analysis identiﬁed the pathways from
the IPA library of canonical pathways that were most sig-
niﬁcant to the dataset. The signiﬁcance of the association
betweenthedatasetandcanonicalpathwayswasassessedby
calculating the ratio of the number of genes from the dataset
that map to the pathway divided by the total number of
moleculesthatexistinthecanonicalpathway.ARight-tailed
Fischer’s Exact Test was then used to calculate a P-value
determining the probability that each biological function
and/ordiseaseassignedtothatdatasetisduetochancealone.
A P\0.05 was considered to be statistically signiﬁcant for
over-representation of the molecules in a given process.
Thus, over-represented functional or pathway processes are
processes which have more focus molecules than expected
by chance. It should be noted that for lists A and B (Figs. 1,
3), due to the small number of genes, pathway over-repre-
sentation is not possible. In this case, IPA was used to map
the genes into their corresponding pathways and biofunc-
tions. Genomatix software (http://www.genomatix.com)
was utilized to identify over-represented transcription factor
binding sites in each of the four gene lists (A–D, Fig. 1).
Chromosome and cytoband enrichment for each of the
genelists(listsA,B,C,andD)aswellasfunctionalannotation
oftheprobesetsintheenrichedchromosomeswasperformed
in DAVID (http://david.abcc.ncifcrf.gov/tools.jsp). A modi-
ﬁed Fisher Exact P-value (the threshold of EASE score) for
geneenrichmentanalysiswasused.Weconsideredthedefault
P B 0.1 to be considered strongly enriched in the annotation
categories. A default value of 2 for the threshold of the min-
imum gene counts belonging to an annotation term was
adopted. Visual representation of the statistically enriched
chromosomes was done using Partek and was presented in
Supplementary ﬁgures 1–3.
Results
Hg Levels
Total blood Hg levels ranged from below the lower
detection limit (1 sample with [Hg]\0.01 lg/l) to 4.3 lg/
l in the TD group, and from below the lower detection limit
(4 samples with [Hg]\0.01 lg/l) to 3.0 lg/l in the AU
group (Fig. 2). The distribution of the linear Hg levels was
signiﬁcantly different from the normal distribution (Kol-
mogorov–Smirnov test: P-value = 3.73E-04, 7.58E-03,
and 6.28E-05 for TD, AU, and TD ? AU, respectively).
However, the distribution of the log2-transformed Hg lev-
els followed a normal distribution (Kolmogorov–Smirnov
test: P = 0.90, 0.97, and 0.94 for TD, AU, and TD ? AU,
respectively). There was no signiﬁcant difference in Hg
levels between the TD and AU groups (P = 0.42 and
P = 0.07, two-sample unpaired t-test, unequal variances
on the linear Hg levels and the log2-transformed Hg levels,
respectively). The mean (±SD) Hg level was 0.60 (±0.82)
and 0.46 (±0.73) lg/l for TD and AU, respectively. The
geometric mean Hg level was 0.29 and 0.16 lg/l for TD
and AU, respectively. The median was 0.30 and 0.16 lg/l
for TD and AU, respectively. The inter-quartile range was
0.14–0.67 and 0.07–0.54 lg/l for TD and AU, respectively.
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were performed on log2-transformed data.
Genes Whose Expression Correlated with Hg Levels
in TD and AU Boys
ANCOVA analyses, in which the TD boys and AU boys
were modeled separately, revealed 1,293 and 1,276 probe
sets, respectively. The expression levels for these genes
signiﬁcantly correlated with Hg levels (P B 0.05, Fig. 3,
bottom left and right circles). Similarly, an ANCOVA
analysis, in which TD and AU boys were combined,
revealed 1,113 genes that correlated with Hg levels, with
P B 0.05 for the interaction Diagnosis (TD, AU)*log2Hg
(Fig. 3, top circle). No genes passed a False-Discovery
Rate ﬁlter in any of the models. Therefore, to reduce the
false discovery inherent to microarray studies, we focused
our analyses on the genes that were identiﬁed in more than
one of the analytical models (intersections in Fig. 3,
denoted as lists A–D). This approach reduced the numbers
of genes approximately 4–6 times.
Genes Whose Expression Levels Correlated with Hg Levels
and Exhibited a Similar Trend in Both TD and AU
There were 15 probe sets whose expression correlated with
Hg levels in both the AU and TD groups, and for which the
correlation coefﬁcients did not signiﬁcantly differ between
the two groups (Fig. 3, list A). Figure 4 shows a heat map
of the partial correlation coefﬁcients with Hg levels for
each of the 15 probe sets (rows) in the TD and AU groups
(columns). Most of the probe sets showed same sign cor-
relations with Hg levels both in the TD and AU groups.
Exceptions were LOC10012902 and TXNDC17 (refer to
abbreviation list for full gene name), which showed dif-
ferent sign correlations with Hg in the TD and AU groups.
The P-values for their interaction (Diagnoses*log2Hg)
were 0.06 and 0.14 which are higher than the statistical
cutoff of P B 0.05. This is why they were not grouped into
list B (most contrasting genes). The 15 probe sets
Fig. 2 Mercury levels in children with autism (AU) and in typically
developing control children from the general population (TD). The X-
axis shows the samples. The Y-axis on the left shows the mercury
(Hg) levels in lg/l and the Y-axis on the right shows the log2Hg
levels. Symbols show Hg levels in AU (black), Hg levels in TD
(gray); and circles show Hg levels (lg/l) and triangles show log2 Hg
values (log2Hg) Fig. 3 Numbers of genes that signiﬁcantly correlate (P B 0.05) with
Hg levels: in children with autism (AU); and in typically developing
control children from the general population (TD). The analyses used
to produce the gene lists for A, B, C, and D are shown in Fig. 1. Three
ANCOVAs were performed for TD, AU, and TD ? AU and the
numbers of signiﬁcant genes are provided for each comparison and
area of overlap
Fig. 4 Genes correlating with Hg levels in AU and TD subjects (List
A). Heat map of the partial correlation coefﬁcients (numbers in each
cell) of the gene expression and Hg levels in TD and AU. Genes are
indicated in the rows and the columns indicate the TD and AU
diagnostic classes
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which are involved mainly in cell death (CADM1, MSH6,
SSTR3, TXNDC17, P-value range 9.92E-04 to 4.40E-
02), signaling (TXNDC17, SSTR3, FEZ2), the immune
response (PXDN, CADM1), and response to oxidative
stress (PXDN) (Table 1). Analysis of the promoter
sequences of these genes using Genomatix software
revealed binding site sequences for the transcription factor
SP1F family (P = 0.032, minimum 86% of sequences).
The target genes are MSH6, SSTR3, PXDN, and LMLN.
Chromosome 2 showed signiﬁcant enrichment with 4 out
of the 15 probe sets (Table 2, Supplementary Fig. 1).
Genes Whose Expression Signiﬁcantly Correlated with Hg
Levels but have Opposite Trends in TD and AU Boys
There were 11 probe sets, whose expression correlated with
Hg levels but in opposite directions for TD compared to AU
(Fig. 3, list B). Figure 5 shows a heat map of the partial
correlation coefﬁcients with Hg levels for each of the 11
probe sets (rows) in the TD and AU groups (columns). The
majority of the genes show positive correlations with Hg
levels in the TD group but negative correlation with Hg
levels in the AU group. The 11 probe sets (Supplementary
Table 1) represent seven annotated genes associated with
cellular assembly and organization (NTRK3, FLNB,
NCAPD3, P-value range 3.31E-04 to 2.91E-02), cellular
compromise (NTRK3, FLNB, P-value range 6.62E-04 to
1.32E-03), small molecule biochemistry (KRT1, NTRK3,
P-valuerange9.92E-04to3.07E-02),vitaminandmineral
metabolism (KRT1, P-value = 9.92E-04), and cell death
(NTRK3, P-value = 1.35E-02) (Table 1). Analysis of the
promoter sequences of these genes using Genomatix soft-
ware revealed binding site sequences for the transcription
factor MYBL family (P = 0.0069, minimum 86% of
sequences) and the AP1R family (P = 0.0289, minimum of
86%ofsequences).ThetargetgenesareFLNBandNTRK3.
No signiﬁcant chromosome nor cytoband enrichment (at
P B 0.1) was observed.
Genes Whose Expression Correlated with Hg Levels in TD
but not in AU Boys
There were 316 probe sets (Supplementary Table 1) whose
expressioncorrelatedwithHglevelsintheTDgroupbutnotin
the AU group (Fig. 3, list C). Of these, 96 were positively
correlated with Hg levels and 220 were negatively correlated
(Supplementary Table 1). Figure 6 shows a heat map of the
tenhighestpositiveandtenlowestnegativepartialcorrelation
coefﬁcients withHglevels in the TDgroupcomparedtotheir
partial correlation coefﬁcients in the AU group. The most
represented molecular and cellular functions were cell death
(37 molecules, P-value range 6.09E-04 to 4.98E-02), cell
morphology (27 molecules, P-value range 9.68E-04 to
4.55E-02), gene expression (39 molecules, P-value range
2.67E-03 to 3.43E-02), cellular assembly and organization
(29 molecules, P-value range 5.34E-03 to 4.98E-02), and
cellcycle (17molecules,P-valuerange 5.39E-03to4.55E-
02) (Table 1). Analysis of the promoter sequences of these
genes using Genomatix software revealed binding site
sequences for the transcription factor ETSF family (P =
0.072,minimum86%ofsequences).Chromosomes19,7,and
13 showed signiﬁcant enrichment with 30, 20, and 10 out of
the 316 probe sets, respectively (Table 2, Supplementary
Fig. 2).Functionalannotationofthegenesonchromosome19
showedthattheyareinvolvedinnucleicacidbinding(43.3%,
P = 0.01) and protein binding (60%, P = 0.09),whereas the
genes on chromosome 7 have protein serine/threonine kinase
activity (13%, P = 0.05). Functional annotation of the genes
on chromosome 13 did not show signiﬁcant over-representa-
tion of molecular functions (at P B 0.1). Cytoband enrich-
mentwasnotedfor22q12.1(3/316,P = 0.03),18q12-q21(2/
316,P = 0.04),12q24.33(3/316,P = 0.06),and19q13.4(4/
316, P = 0.08).
Genes Whose Expression Correlated with Hg Levels in AU
but not in TD Boys
There were 189 probe sets (Supplementary Table 1) whose
expression correlated with Hg levels in the AU group but
not in the TD group (Fig. 3, list D). Of these, 62 were
positively correlated with Hg levels and 127 were nega-
tively correlated (Supplementary Table 1). Figure 7 shows
a heat map of the ten highest positive and ten lowest
negative partial correlation coefﬁcients with Hg levels in
the AU group compared to their partial correlation coefﬁ-
cients in the TD group. The most represented molecular
and cellular functions for the 189 probe sets (Table 2) were
cell morphology (DIRAS1, PIP5K3, ANK1, CAPZB,
ASAP1, RRBP1, P-value range 1.64E-04 to 4.39E-02),
amino acid metabolism (GGT1, SLC25A22, SLC7A8, P-
value range 7.33E-03 to 3.56E-02), antigen presentation
(PPT2, NLRP1, NOD1, SLC11A1, HLA-DQA1, and HLA-
DQB1, P-value range 7.44E-03 to 1.77E-02), carbohy-
drate metabolism (PIP5K3, SLC35B4, P-value range
7.44E-03 to 2.95E-02), and cell cycle (SASS6, PIP5K3,
AMACR, P-value range 7.44E-03 to 2.22E-02). Analysis
of the promoter sequences of these genes using Genomatix
software revealed binding site sequences for the tran-
scription factor KLF family (P = 0.00015, minimum 86%
of sequences). Chromosomes 1 and 8 showed signiﬁcant
enrichment with 25 and 11 out of the 189 probe sets,
respectively (Table 2, Supplementary Fig. 3). Functional
annotation of the genes on chromosome 1 showed that they
are involved in heat shock protein binding (8%, P = 0.07),
whereas the genes on chromosome 8 are involved in
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123Table 1 Top biological functions for the gene lists A, B, C, D
Top functions Genes (? [in bold]; - [in italics])
List A: Common genes
Apoptosis MSH6, CADM1, SSTR3
Cell-to-cell signaling interaction CADM1
Cell-mediated immune response—cytokine secretion CADM1
Immune response PXDN
Response to oxidative stress PXDN
Transcription regulation, DNA dependent CNOT3
List B: Contrasting genes
Cellular assembly and organization
Synapse density and axon extension NTRK3 (TD/AU)
Chromosome segregation and alignment NCAPD3 (TD/AU)
Cytoskeleton anchoring and biogenesis FLNB (TD/AU)
Cellular compromise
Vestibular ganglion neuron degeneration NTRK3 (TD/AU)
Actin ﬁlament disorganization FLNB (TD/AU)
Small molecule biochemistry
Biotin binding KRT1 (TD/AU)
D-Glucose uptake NTRK3 (TD/AU)
Apoptosis of neurons and granular cells,
sensory neuron survival
NTRK3 (TD/AU)
List C: Genes correlating with mercury (TD only)
Cell death
Apoptosis (A.) of brain cells NFATC4, BAD, BDNF, GCLM
Axon recovery and regeneration BDNF, RTF4
Apoptosis of corticospinal neurons BDNF
Killing of neurons BAD, BDNF
Killing of normal cells BAD, BCL2L11, BDNF
Cell death of interneurons BDNF
Normal cell death delay BCL2L11, BDNF
Brain cell death NFATC4, BAD, BCL2L11, BDNF, GCLM
Brain cell loss ALS2, BDNF
Memory B cell and neuron survival BRAF, BCL2L11, BDNF
Pro-B lymphocyte survival BCL2L11, TCF3
Apoptosis of pre-T lymphocytes BCL2L11
Cell morphology
Red blood cell morphology SCARB1, KLF2
Memory B cell division delay ZBTB16
Mitochondria transmembrane potential ABL1, ZBTB16, GNLY, AP2A2, BCL2L11, MUC1, TCF3
Mitochondria permeabilization ABL1, GNLY, BCL2L11
Neuron branching ABL1, BDNF
Axon sprouting and projection BDNF, RTN4
Synapse plasticity NFATC4, BDNF, PMCH
Axon remodeling SFRP1
Gene expression
Transcription ABL1, ARID1A, BHLHB2, BMPR2, FAM130A1, FOXK1,
HOXB4, MAFF, NFATC4, SMAD2, ZBTB16, ZBTB38,
AP2A2, BAD, BDNF, CEBPD, FERD3L, FOXI1, GARNL1,
HIF3A, KLF2, KLF12, LANCL2, MTRF1, RNF141, SFRP1,
STUB1, SUB1, TCF3, TRIB3, ZNF10, ZNF174, ZNF254
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123protein kinase activity (11%, P = 0.1). Cytoband enrich-
ment was noted for 1p33 (3/189, P = 0.02) and 6p21.3 (5/
189, P = 0.05).
Analysis of All Genes Correlating with Hg Levels in AU
and/or TD
Finally, we performed an analysis of all genes whose
expression correlated with Hg levels regardless of diag-
nostic group or sign of correlation (all four gene lists
combined—A–D). The rationale for doing this was to ask
whether there were genes in all four lists that were asso-
ciated with the same functional networks. The IPA analysis
revealed that the top molecular and cellular functions of the
genes correlating with Hg levels were cell morphology (29
molecules, P-value range 1.19E-03 to 4.01E-02), cell
death (24 molecules, P-value range 2.35E-03 to 4.60E-
02), cellular assembly and organization (25 molecules,
P-value range 3.87E-03 to 4.01E-02), cellular movement
(8 molecules, P-value range 3.87E-03 to 4.988E-02), and
Table 1 continued
Top functions Genes (? [in bold]; - [in italics])
Expression ARID1A, BHLHB2, BMPR2, NFATC4, SMAD2, ZBTB38,
BAD, BDNF, CEBPD, HIF3A, TCF3, RGNEF
Activation BHLHB2, SSBP1, CEBPD, TCF3
Co-Activation of TCF binding site MUC1
Transactivation ABL1, ARID1A, SH3BP2, SMAD2, ZBTB16, BDNF,
CEBPD, HIF3A, KLF2, PRKDC, STUB1, SUB1, TCF3, ZNF10
Repression ZBTB16
List D: Genes correlating with mercury (AU only)
Cell morphology
Vacuolation of embryonic, epithelial
and kidney cell lines
DIRAS1, PIP5K3
Length of actin stress ﬁbers ANK1
Morphology of intercalated discs and myoﬁbrils CAPZB
Morphology of focal adhesions ASAP1
Elongation of gonadal cell lines RRBP1
Amino acid metabolism
Glutamine utilization, glutathione
and L-cysteine metabolism quantity
GGT1
Transport of L-amino acid SLC25A22, SLC7A8
Antigen presentation
Inﬁltration of multinucleated giant cells PPT2
Antibacterial response of organism SLC11A1, NLRP1, NOD1
Antigen processing and presentation of peptide
or polysaccharide antigen via MHC class II
HLA-DQA1, HLA-DQB1
Direction of correlation between gene expression level and blood mercury level is presented in bold and italics (bold = positive correlation,
italics = negative correlation). For List A, direction of correlation is based on the correlation of gene expression and mercury levels in the TD
class. For List B, directions of correlations for mercury levels and gene expression in both TD and AU classes are presented in parenthesis. For
List C, directions of correlations of mercury and gene expression levels in the TD class are presented. For List D, directions of correlations of
mercury and gene expression levels in the AU class are presented
Table 2 Chromosome enrichment for the probe sets from the four list (lists A, B, C, and D)
List* Probe sets in
list, count
Chromosome Probe
set, count
% probe
sets/chromosome
P-value
A 15 2 4 26.7 0.04
C 316 19, 7, 13 30, 23, 10 9.3, 7.2, 3.1 0.02, 0.03, 0.08
D 189 1, 8 25, 11 13.1, 5.8 0.04, 0.08
Signiﬁcant enrichment was considered at P B 0.1
* List B did not show any signiﬁcant chromosome enrichment at P B 0.1
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123cellular development (15 molecules, P-value range 5.72E-
03 to 4.49E-02). The top disease and disorder biofunctions
correlating with Hg levels were cancer (30 molecules,
P-value range 6.03E-04 to 4.98E-02), hematological
disease (14 molecules, P-value range 6.02E-04 to 4.89E-
02), genetic disorder (185 molecules, P-value range
1.81E-03 to 3.98E-02), neurological disease (103 mole-
cules, P-value range 2.35E-03 to 3.98E-02), and skeletal
and muscular disorders (11 molecules, P-value range
1.04E-02 to 3.98E-02). The top canonical pathways
correlating with Hg levels were GABA receptor signaling
(4/55 molecules, P-value 1.16E-02), lysine degradation
(7/234 molecules, P-value 2.74E-02), thyroid cancer sig-
naling (3/45 molecules, P-value 4.04E-02), and cyanoa-
mino acid metabolism (2/64 molecules, P-value 4.98E-
02). Figure 8 shows the IPA network with the highest
score. It is notable that many genes are regulated in this
network, but that the Hsp70, Hsp90, proteasome, NFjB,
Raf, and caspase nodes themselves are not regulated.
Comparison of Genes Correlating with Hg Levels Only
in TD (List C) and Only in AU (List D)
To gain more insight into the associations between tran-
script levels and circulating Hg levels in the TD and the
AU children, and to evaluate the biological signiﬁcance of
the differences between the TD and AU boys, we compared
the genes that correlated with Hg levels only in the TD
group (List C), and genes that correlated with Hg levels
only in the AU group (List D). We split each gene list into
two lists, based on the direction of the correlation coefﬁ-
cients—into a list of genes whose expression positively
correlates with Hg levels and into a list of genes whose
expression negatively correlates with Hg levels. The IPA
Fig. 5 Genes correlating with Hg levels both in AU and TD, except
that the correlation coefﬁcients are signiﬁcantly different from each
other (List B). Heat map of the partial correlation coefﬁcients
(numbers in each box) of the gene expression and Hg levels in TD and
AU. Genes are indicated in rows, and diagnoses (TD or AU) are
indicated in the columns
Fig. 6 Genes with the ten highest positive and the ten lowest
negative correlations of gene expression with Hg levels for the TD
subjects (List C). Heat map of the partial correlation coefﬁcients
(numbers in the boxes) of the gene expression and Hg levels in TD
and AU. Genes are on the Y-axis, and diagnoses are on the X-axis
Fig. 7 Genes with the ten highest positive and the ten lowest
negative correlations of gene expression with Hg levels for the AU
subjects (List D). Heat map of the partial correlation coefﬁcients
(numbers in boxes) of the gene expression and Hg levels in TD and
AU. Genes are on the Y-axis, and diagnoses are on the X-axis
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123canonical pathways over-represented in at least one of the
four categories (TD (?) and TD (-) from List C, and AU
(?) and AU (-) from List D, signs represent the direction
of the partial correlation) are shown in Fig. 9. The TGF-
beta signaling pathway (Fig. 10) and molecular mecha-
nisms of cancer (P = 3.48E-02, 2/86 and P = 3.66E-02,
4/370, respectively) are over-represented in the positively
correlating genes between Hg level and gene expression in
the TD group. Lysine degradation (P = 3.63E-02, 4/234)
was over-represented in the negatively correlating genes
between Hg level and gene expression in the TD group.
p38 MAPK signaling and a-adrenergic signaling were
over-represented in the positively correlating genes
between Hg level and gene expression in the AU group.
Discussion
Though some of the genes and pathways are similar, the
major ﬁnding of the study is that almost all of the genes
that correlate with circulating Hg levels in AU boys are
different from TD boys, and almost all of the genes that
correlate with circulating Hg levels in TD boys are dif-
ferent from AU boys. These transcriptional differences
were observed even though the Hg levels were low and not
signiﬁcantly different between the groups in our study.
Since the data reported are only correlations, no conclu-
sions can be drawn as to whether Hg plays any role in the
pathogenesis of autism based upon the current results.
Given the low Hg levels and the fact that this is a cross-
sectional study, no cause and effect relationship should be
drawn from the current data. Though the data can be
interpreted in several ways, we suggest that the different
transcriptional programs associated with Hg in AU com-
pared to TD subjects may be related to the genetic differ-
ences in the two groups of children.
Common Genes (List A and List B) and Common
Pathways
The major ﬁnding of this study is that very few genes that
correlated with Hg levels in AU subjects also correlated
with Hg levels in TD subjects. There were only 15 genes
that correlated with Hg levels in both the TD and AU
groups—and that were not signiﬁcantly different between
the two groups. These genes were involved in apoptosis,
the immune response, and response to oxidative stress.
Moreover, there were only 11 genes whose expression
correlated inversely with Hg levels in AU compared to TD
subjects—that is genes correlating with Hg levels in both
groups but in opposite directions. These genes were
involved in pathways contributing to neuronal develop-
ment and neuronal survival and cell death. Notably, one
gene (FLNB, ﬁlamin B, beta (actin binding protein 278)),
which was positively correlated with Hg levels in TD and
negatively correlated in AU subjects, is involved in
Fig. 8 The number one
network derived from all of the
genes in Lists A, B, C, and D
which participate in cell death,
protein conformation, cellular
assembly and organization,
cellular function, and
maintenance
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123Fig. 9 Canonical pathways
over-represented in at least one
of the four categories from the
genes that correlate with
mercury levels in TD subjects
(List C) and that correlate with
mercury levels in AU subjects
(List D). TD
(?) = red = positively
correlated genes from List C.
TD (-) = blue = negatively
correlated genes from List C.
AU (?) = hatched
red = positively correlated
genes from List D. AU (-)
= hatched blue = negatively
correlated genes from List D
Fig. 10 TGF-b signaling
pathways. The colors represent
genes whose expression
correlates with blood mercury
levels in typically developing
boys (TD) but not in boys with
autism (AU). Red = positive
correlation
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123anchoring and biogenesis of cytoskeleton and organization
of actin ﬁlaments (Xu et al. 1998; Tu et al. 2003; Leedman
et al. 1993). A number of studies show that most heavy
metals, including zinc, arsenic, mercury, and cadmium, can
disrupt actin and microtubules in intact cells (Templeton
2000).
The analysis of all genes correlating with Hg levels in
all AU and TD subjects showed a number of common
networks. Figure 8 is a good example where different
genes from the different groups are regulated within the
same network. This could suggest that similar functions
might be accomplished with different genes in AU com-
pared to TD, and that homeostasis is maintained in spite of
the genetic differences of AU and TD subjects.
Genes Correlating with Hg Levels in TD but not in AU
Boys (List C)
Thus, most of the genes whose expression correlated with
Hg levels in the TD group were different from those whose
expression correlated with Hg levels in the AU group. For
the TD subjects, the top biological function for the genes
that correlated with Hg levels was cell death. Some of these
genes were involved in apoptosis of neurons (NFATC4,
BAD, BDNF) (Graef et al. 2003; Ottilie et al. 1997; Hoey
et al. 1995; Botta et al. 2004; Kerschensteiner et al. 1999;
Mamounas et al. 1995), survival of neurons, recovering and
regeneration of axons (BDNF, RTN4) (Kerschensteiner
et al. 1999; GrandPre et al. 2000), apoptosis of pre-T
lymphocytes (BCL2L11) (Bouillet et al. 1999), survival of
pro-B lymphocytes, and survival of memory B cells
(BRAF, BCL2L11, BDNF, TCF3) (Oliver et al. 2004;
Fischer et al. 2007). It is interesting that most of these
correlations are negative. Chronic exposure to low con-
centrations of heavy metals, including mercury, causes
immune dysfunction related in large part to apoptosis of
leukocytes (Pollard and Hultman 1997; Zelikoff and
Gardner 1996; Laiosa et al. 2007; Madureira et al. 2007;
Ziemba et al. 2005; Mondal et al. 2005; McCabe et al.
2003, 2005; Cunha et al. 2004; Sarmento et al. 2004; Kuo
and Lin-Shiau 2004; Colombo et al. 2004; Field et al.
2003). Both inorganic and organic mercurials cause human
T-cell apoptosis with mitochondria being the target orga-
nelle for the induction of cell death (Shenker et al. 1999).
In addition, microarray analysis of Hg-induced changes in
gene expression in human liver carcinoma (HepG2) cells
revealed genes involved in apoptosis and metabolic regu-
lation with signiﬁcant effects on genes involved in immune
system pathways (Ayensu and Tchounwou 2006). How-
ever, the levels of Hg applied to the cells were much higher
than the Hg levels of the subjects in our study.
The second major biological function for genes that
correlated with Hg levels in TD subjects was cell
morphology and cell death. Mercury-induced cell death can
be apoptotic or nonapoptotic. The nonapoptotic cell death
produced by mercury is associated with a speciﬁc cellular
morphology (Pollard et al. 1997, 2000). Mercury-induced
apoptosis results from dys-regulated signal transduction
that leads to inactivation of enzymes, generation of free
radicals and peroxides, protein conformation changes, and
inhibition of transport processes which disrupt cell mem-
brane permeability (Tchounwou et al. 2003; Clarkson and
Magos 2006; Counter and Buchanan 2004; Zahir et al.
2005). Genes associated with transmembrane potential and
permeabilization of mitochondria correlated with Hg levels
in TD subjects in our study. Mercury-induced membrane
changes of mitochondria associated with glutathione
imbalance and antioxidant defenses have been reported in
TD versus AU transformed lymphoblastoid lines (James
et al. 2009). Mercury increases mitochondrial permeability,
which is characterized both by a decline in transmembrane
potential and intracellular pH, as well as the generation of
reactive oxygen species and a decline in T-cell GSH con-
tent (Shenker et al. 2000). In our study, Granulysin
(GNLY) showed a positive correlation with Hg levels in
the TD group. GNLY is a cytolytic and pro-inﬂammatory
molecule, which contributes to mitochondrial damage
(Krensky and Clayberger 2009). B-cell lymphoma 2-like
protein 11 (apoptosis facilitator) (BCL2L11) showed a
negative correlation with Hg in the TD group in our study.
BCL2L11 (also known as BIM) is a BH3-only protein from
the Bcl-2 family (Youle and Strasser 2008), whose family
members are the main regulators of programmed cell death
via the mitochondrial (intrinsic) apoptotic pathway. Inter-
actions between pro- and anti-apoptotic proteins of the
Bcl-2 family decide the fate of cells in response to stress
signals. BCL2L11 is essential for hematopoietic homeo-
stasis and thymocyte negative selection, and suppresses
autoimmunity (Youle and Strasser 2008).
Some of the cell morphology genes that correlated with
Hg levels in TD subjects also have functions within the
central nervous system. These included genes that affect
neuronal survival (ABL1 (?), BDNF (-)), sprouting and
projection of axons (BDNF (-), RTN4 (-)), plasticity of
the synapse (BDNF (-), NFATC4 (?), PMCH (-)), and
remodeling of axons (SFRP1 (-)) (Kerschensteiner et al.
1999; GrandPre et al. 2000; Gascon et al. 2007; DeFreitas
et al. 2001; Mamounas et al. 2000; Fournier et al. 2001;
Seil 1998; Groth and Mermelstein 2003; Krylova et al.
2002). It is possible that mercury affects these genes in the
brain as well as the blood, and this might relate to neuro-
toxicity observed following exposure to much higher levels
of mercury (Rice 2008; Guzzi and La Porta 2008).
We observed a negative correlation between GCLM and
Hg levels in TD, but no correlation in AU. GCLM is a
member of the glutamate-cysteine ligase complex, which is
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and is the major route of mercury detoxiﬁcation.
James et al. (2009) observed a reduced glutathione
reserve capacity in both cytosol and mitochondria in lym-
phoblastoid cells derived from children with autism when
compared to children without autism. Glutathione reserve
capacity is an indicator of systemic redox status that can be
used to assess and treat individuals at risk of oxidative
stress-related pathology (Jones 2006a, b). In our study, we
observed a negative partial correlation between GCLM
transcript abundance and Hg levels in the TD group, while
there was no signiﬁcant correlation in the AU group.
GCLM is transcriptionally regulated in human HepG2 cells
(Lee et al. 2006). We also observed a negative partial
correlation between GGT1 transcript abundance and Hg
levels in the AU group, while there was no signiﬁcant
correlation in the TD group (see section ‘‘Genes Whose
Expression Correlates with Hg Levels in AU but not in TD
Boys (List D)’’). GGT1 is involved in the utilization of
L-glutamate, L-cysteine, and glutathione metabolism. It is
involved in the generation of L-glutamate, which is a sub-
strate for glutathione synthesis. Thus, if there is negative
regulation of this gene, there may be less substrate for the
glutathione biosynthesis pathway, which may affect the
redox status. Overall, our studies of transcript abundance in
blood of AU and TD boys are difﬁcult to relate to the in
vitro studies of AU and TD lymphoblastoid cell lines
except to say that both approaches show associations
between genes in the glutathione pathways and Hg levels.
CDKN2AIPNL and ZMYM6 negatively correlated with
Hg levels in this study and both were downregulated with
mercury treatment in human liver carcinoma (HepG2) cells
(Ayensu and Tchounwou 2006). ALDH3B1, RPS9, SUB1,
and VPS25 also were negatively correlated with Hg in TD
subjects in this study and were downregulated in Hg-trea-
ted yeast (Jin et al. 2008).
Genes whose expression correlated similarly with Hg
levels both in TD and AU (List A) and whose expression
correlated with Hg levels only in the AU group (List D)
have transcription factor (TF) binding sites for SP1 and
Kruppel-like factor (KLF)-like TFs, respectively. KLF6,
which is an Sp1-like zinc ﬁnger transcription factor, is a
transactivator of inducible nitric oxide synthase (iNOS)
(Warke et al. 2003), which produces NO and modulates
inﬂammatory signals and oxidative stress (Mungrue et al.
2003).
Genes Whose Expression Correlates with Hg Levels
in AU but not in TD Boys (List D)
One of the top biological functions in the list of genes that
correlated with Hg levels in AU but not TD boys was
amino acid metabolism. The genes included gamma-
glutamyltransferase (GGT1/2/3; probe 244179_x_at); as
well as solute carrier family 25 (mitochondrial carrier:
glutamate), member 22 (SLC25A22 (-)), and solute car-
rier family 7 (cationic amino acid transporter, y? system),
member 8 (SLC7A8 (-)) which are involved in the
transport of L-amino acids (Pineda et al. 1999). SLC7A8,
which had negative partial correlation with Hg levels in the
AU group in our study, was upregulated in mercury-treated
yeast cells (Jin et al. 2008).
FAF1 (Fas-associated factor 1) expression was posi-
tively correlated with Hg levels in AU but not TD subjects.
Fas is a member of the tumor necrosis receptor factor
family, which can induce apoptosis when activated by Fas-
ligand binding (Chu et al. 1995). Apoptosis induced by Fas
plays an important role in the development and function of
the immune system (Lowin et al. 1994; Nagata 1994).
Genetic studies in mice show that defects in Fas-mediated
apoptosis resulted in abnormal development and function
in the immune system (Takahashi et al. 1994). FAF-1 also
inhibits the NF-jB activation induced by various stimuli,
including tumor necrosis factor-a, interleukin-1b, and
lipopolysaccharide (Park et al. 2004). NF-jB is a central
regulator of genes involved in the immune response,
inﬂammatory response, and apoptosis (Beg and Baltimore
1996; Pahl 1999; Baldwin 1996).
CHCHD4 (negatively correlated with Hg level in AU),
ELOVL1, SLC7A8, and Cxorf34 (positively correlated
with Hg level in AU) responded to mercury in yeast in the
same direction as in our AU subjects. NTHL1 (positively
correlated with Hg level in AU) was downregulated in
yeast after mercury treatment, whereas MYBBP1A (posi-
tively correlated in AU) was up- or downregulated
depending on the treatment dose (Jin et al. 2008).
HLA-DQ, an ab heterodimer of the MHC Class II type
which is a cell surface molecule found on antigen pre-
senting cells, presents antigens to T-lymphocytes (Germain
and Margulies 1993; Janeway et al. 1997; Kwok and Nepom
1998). The a and b chains are encoded by HLA-DQA1 and
HLA-DQB1, respectively, and both the a-a n db-chains vary
greatly in the population. Different DQ isoforms can bind to
and present different antigens to T-cells. Several lines of
evidence suggest that mercury toxicity depends on the
mercury species, dosage, individuality, and the type of MHC
association (Ayensu et al. 2004;H a n l e ye ta l .1997, 2002).
Moreover, chronic exposure to low concentrations of heavy
metals such as mercury results in immune dysfunction
(Ayensu et al. 2004;H a n l e ye ta l .1997, 2002). Immune
dysregulation has been observed in autism, and has been
postulated to play a role in the development and pathogen-
esis of autism in some cases (Warren et al. 1996, 1997;
Singh and Rivas 2004; Ashwood et al. 2006; Gupta et al.
1996). In this study, we found that HLA-DQA1 was nega-
tively correlated, whereas HLA-DQB1 was positively
44 Neurotox Res (2011) 19:31–48
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both were downregulated in response to mercury in human
liver carcinoma (HepG2) cells (Ayensu and Tchounwou
2006).
Comparison of Genes Correlating with Hg Levels Only
in TD or Only in AU (List C or D)
There is a different association between transcript level and
circulating Hg levels in the TD and AU subjects that
involves genes from the TGF-b signaling pathway. TGF-b
signaling regulates cell growth, cell differentiation, cellular
homeostasis, apoptosis, and immune responses. TGF-b
binds to and activates the TGF-b receptor, which then
activates the SMAD family of transcriptional regulators.
SMAD2 and SMAD3 mediate TGF-b and activin signals,
while SMAD1, SMAD5, and SMAD8 act downstream of
bone morphogenetic proteins (BMPs) (Zhang and Derynck
1999; ten Dijke et al. 2000; Massague and Wotton 2000).
SMADs dimerize with SMAD4 and translocate to the
nucleus where the complex modulates transcription of
target genes. In our study, we found bone morphogenetic
protein receptor type 2 (serine/threonine kinase) (BMPR2)
and SMAD2 to be positively correlated with Hg levels in
TD but not in AU subjects. Notably, Ashwood et al. (2008)
observed decreased TGF-b1 plasma levels in children with
autism spectrum disorders when compared to typically
developing controls.
Hg Levels in AU and TD
Hg levels in children from the CHARGE study with and
without autism have been studied in detail (Hertz-Picciotto
et al. 2009). The Hg levels in the TD and AU groups were
quite similar in this sample to those in the larger CHARGE
sample: means of 0.60 lg/l for TDs in both groups, and
means of 0.46 and 0.49 lg/l for the AU/ASD children in
this subsample and the larger study (Hertz-Picciotto et al.
2009). Thus, the sample of subjects in this study is repre-
sentative of the CHARGE study as a whole. None of the
samples used in this study had Hg levels higher than the
EPA reference level of 5.8 lg/l. The median Hg concen-
tration and inter-quartile range were comparable to those of
the U.S. population of children ages 1–5 years in 1999–
2002 (McDowell et al. 2004). It is notable, therefore, that
the gene expression differences described here occurred in
the EPA allowable range. This is consistent with previously
reported dose-dependent effects of Hg (Tchounwou et al.
2003; Clarkson and Magos 2006; Counter and Buchanan
2004; Zahir et al. 2005) and with a dose-dependent tran-
scriptional response in human liver carcinoma cell lines
treated with mercury (Ayensu and Tchounwou 2006). It is
important to emphasize that acute intoxication with much
higher mercury concentrations or even chronic exposure to
much higher Hg concentrations might produce different
transcript associations.
Limitations of the Study
Samples collected from children ages 2–5 in this study do
not directly address the role of Hg as a possible causal
factor for autism which likely begins in utero or shortly
after birth. In addition, it is important to emphasize that
one cannot infer cause and effect from the data presented
in this study. Our data shows that there are associations
between transcript levels and circulating Hg levels which
are different in the AU compared to the TD group. It is
possible that these low levels of Hg cause changes of
gene expression in the white blood cells that could affect
the function of immune cells that could play a role in the
pathogenesis of autism. Alternatively, and perhaps more
likely, the altered transcriptomic associations with low
levels of Hg in AU may have no functional effect on
immune cells, brain, or other organs. Further studies on
protein levels of the genes whose expression was asso-
ciated with mercury levels should be conducted. Protein
levels may or may not reﬂect RNA levels, particularly in
stressed cells. Again, correlation does not mean causality
and extreme caution should be exercised when interpret-
ing the correlations reported here. In addition, since this is
a one-time study, the correlation of an individual
gene might not be replicated in future studies due to
stochasticity.
The P-values which were used to derive the gene lists
indicate statistical but not biological signiﬁcance. It is
unclear what level of correlation of gene expression and Hg
levels represents biological signiﬁcance. Correlation is also
affected by ‘‘outlying’’ values. One way of reducing this
effect is by log-transforming the data as was done here.
Also, the somewhat unequal sample sizes may affect the
calculation of the P-values and thus lead to some skewing
of the data. The strengths of the correlations were not large
for most of the identiﬁed genes. Therefore, caution should
be exercised regarding the correlation of gene expression
with Hg level for a given gene.
No gene reported here passed a multiple comparison
correction for statistical signiﬁcance. We addressed this
problem in part by focusing on genes common to at least
two of the ANCOVAs. However, the ﬁnding that so few
genes correlated with Hg levels in both AU and TD sub-
jects implies that multiple comparisons had no impact on
the major conclusion of this study: AU and TD children
have different associations between transcript level and
circulating Hg levels. Increasing multiple comparisons
would have made it likely that there would be many
Neurotox Res (2011) 19:31–48 45
123transcripts that correlated with Hg and were common to the
AU and TD groups.
This study evaluated a single sample of blood where
only 5% of the body burden of Hg is found (Burbacher
et al. 2005; Stinson et al. 1989). The different Hg species
were not measured (Goldman and Shannon 2001; Clarkson
2002). It is likely that different Hg species induce speciﬁc
genes and affect speciﬁc enzymes that mediate Hg species
speciﬁc toxicity (Clarkson and Magos 2006; Aschner et al.
2006).
The observed correlation between Hg levels and gene
expression might be due to other factors that were not
included in our ANCOVA models. Different diets of AU
compared to TD subjects might affect gene expression. For
example, ﬁsh is a major source of organic mercury intake
and in the larger CHARGE study sample (Hertz-Picciotto
et al. 2009) accounted for the differences in mercury levels
between subjects. Fish contain n-3 polyunsaturated fatty
acids, which are potent regulators of gene expression (Price
et al. 2000). It is possible that some of the associations
observed in this study are confounded by n-3 polyunsatu-
rated fatty acids levels or other molecules found in ﬁsh.
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